Trump’s 25% Pharma Tariffs: Impact on Top Indian Drugmakers
President Donald Trump’s proposed 25% tariffs on pharmaceutical imports have raised concerns for Indian drugmakers that depend heavily on the U.S. market.…
Browse research
President Donald Trump’s proposed 25% tariffs on pharmaceutical imports have raised concerns for Indian drugmakers that depend heavily on the U.S. market.…
Bird Construction Inc (BDT:CA), a renowned Canadian construction and maintenance firm with a legacy spanning over a century, is gearing up…
Aecon Group Inc (ARE:CA), a leading North American construction and infrastructure developer, continues to draw investor attention amid shifting market dynamics. With…
First National Financial Corporation (FN:CA), one of Canada’s largest non-bank mortgage originators and underwriters, is preparing to report its financial performance…
Canfor Corporation (CFP:CA), a leading global manufacturer of high-value, low-carbon forest products, continues to navigate a challenging market environment. With operations…